Clinical predictors to identify paroxysmal atrial fibrillation after ischaemic stroke

European Journal of Neurology

Volumn 21, Issue 1, 2014, Pages 21-27

  Wohlfahrt, J ^a   Stahrenberg, R ^a   Weber Kruger M ^a   Groschel S ^b   Wasser, K ^a   Edelmann, F ^a   Seegers, J ^a   Wachter, R ^a   Groschel K ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atrial fibrillation; Clinical trial; Holter ECG; Ischaemic stroke; Paroxysmal atrial fibrillation; Stroke unit

Indexed keywords

ALTEPLASE; C REACTIVE PROTEIN; CREATININE;

AGE; AGED; ALGORITHM; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; TRANSTHORACIC ECHOCARDIOGRAPHY;

ATRIAL FIBRILLATION; CLINICAL TRIAL; HOLTER ECG; ISCHAEMIC STROKE; PAROXYSMAL ATRIAL FIBRILLATION; STROKE UNIT;

AGED; ALGORITHMS; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; MALE; STROKE;

EID: 84890116673     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12198     Document Type: Article

References (27)

1. Grau AJ, Weimar C, Buggle F, et al. Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32: 2559-2566.
2. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007; 146: 857-867.
3. Alberts MJ, Eikelboom JW, Hankey GJ. Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation. Lancet Neurol 2012; 11: 1066-1081.
4. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007; 38: 1655-1711.
5. Liao J, Khalid Z, Scallan C, et al. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke 2007; 38: 2935-2940.
6. Stahrenberg R, Weber-Krüger M, Seegers J, et al. Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous Holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke 2010; 41: 2884-2888.
7. Gumbinger C, Krumsdorf U, Veltkamp R, et al. Continuous monitoring versus Holter ECG for detection of atrial fibrillation in patients with stroke. Eur J Neurol 2012; 19: 253-257.
8. Ziegler PD, Glotzer TV, Daoud EG, et al. Incidence of newly detected atrial arrhythmias via implantable devices in patients with a history of thromboembolic events. Stroke 2010; 41: 256-260.
9. Elijovich L, Josephson SA, Fung GL, et al. Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis 2009; 18: 185-189.
10. Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
11. Alhadramy O, Jeerakathil TJ, Majumdar SR, et al. Prevalence and predictors of paroxysmal atrial fibrillation on Holter monitor in patients with stroke or transient ischemic attack. Stroke 2010; 41: 2596-2600.
12. Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 123: 104-123.
13. Healey JS, Connolly SJ, Gold MR, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 2012; 366: 120-129.
14. Hohnloser SH, Pajitnev D, Pogue J, et al. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. J Am Coll Cardiol 2007; 50: 2156-2161.
15. Doliwa Sobocinski P, Anggardh Rooth E, Frykman Kull V, et al. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace 2012; 14: 1112-1116.
16. Suissa L, Bertora D, Lachaud S, et al. Score for the targeting of atrial fibrillation (STAF): a new approach to the detection of atrial fibrillation in the secondary prevention of ischemic stroke. Stroke 2009; 40: 2866-2868.
17. Malik S, Hicks WJ, Schultz L, et al. Development of a scoring system for atrial fibrillation in acute stroke and transient ischemic attack patients: the LADS scoring system. J Neurol Sci 2011; 301: 27-30.
18. Bugnicourt JM, Flament M, Guillaumont MP, et al. Predictors of newly diagnosed atrial fibrillation in cryptogenic stroke: a cohort study. Eur J Neurol 2012; 20: 1352-1359.
19. Lazzaro MA, Krishnan K, Prabhakaran S. Detection of atrial fibrillation with concurrent Holter monitoring and continuous cardiac telemetry following ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2012; 21: 89-93.
20. Vaziri SM, Larson MG, Benjamin EJ, et al. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994; 89: 724-730.
21. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
22. Stahrenberg R, Edelmann F, Haase B, et al. Transthoracic echocardiography to rule out paroxysmal atrial fibrillation as a cause of stroke or transient ischemic attack. Stroke 2011; 42: 3643-3645.
23. Kobayashi A, Iguchi M, Shimizu S, et al. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation. J Stroke Cerebrovasc Dis 2012; 21: 310-317.
24. Rizos T, Guntner J, Jenetzky E, et al. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke 2012; 43: 2689-2694.
25. Kallmunzer B, Breuer L, Hering C, et al. A structured reading algorithm improves telemetric detection of atrial fibrillation after acute ischemic stroke. Stroke 2012; 43: 994-999.
26. Wachter R, Stahrenberg R, Gröschel K. Subclinical atrial fibrillation: how hard should we look? Heart 2013; 99: 151-153.
27. Wachter R, Lahno R, Haase B, et al. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia - the Find-AF study. PLoS ONE 2012; 7: e34351.